Minireviews
Copyright ©The Author(s) 2020.
World J Clin Cases. Aug 26, 2020; 8(16): 3411-3430
Published online Aug 26, 2020. doi: 10.12998/wjcc.v8.i16.3411
Table 3 Modified from reference 98 Common Terminology Criteria for Adverse Events v4.03 from April 2011 through April 2018
Modified adverse events according to common terminology criteria for adverse events
Grade 1MildAsymptomatic or mild symptoms; clinical or diagnostic observations only
Grade 2ModerateEnzyme elevation or radiologic findings only; minimal, local or noninvasive intervention indicated
Grade 3SevereLipase elevation > 2 times normal (60 U/L), severe pain, vomiting, needing medical intervention; hospitalization or prolongation of hospitalization indicated
Grade 4Life-threatening consequencesUrgent intervention indicated
Grade 5DeathDeath related to adverse events